Bioporto A/S Equity 2024

Bioporto A/S Aktienanalyse

What does Bioporto A/S do?

Bioporto A/S is a Danish company specializing in the development, production, and sale of diagnostic products for use in medical diagnostics. It was founded in 1999 and is headquartered in Hellerup, near Copenhagen. The company's history is closely connected to the development and marketing of biomarkers and tests. Biomarkers are biological substances that can serve as indicators for certain diseases or health conditions. Bioporto A/S specializes in the identification and development of these biomarkers, playing an important role in medical diagnostics. Its business model is based on the development and production of medical diagnostic products based on the identification of biomarkers. The company focuses on various sectors such as clinical diagnostics, the life science industry, and research and development in the diagnostic field. Bioporto A/S offers a wide range of products that cater to different customer needs. In the field of clinical diagnostics, the company provides a variety of tests and test kits for the identification of biomarkers. These include tests for determining N-terminal prohormones of brain natriuretic peptides (NT-proBNP), a biomarker used in the diagnosis of heart failure, as well as tests for detecting protein C and S, hormone receptors, or Addison's disease. In the life science industry, Bioporto A/S offers products used in the exploration of biomarkers, antibodies, and proteins. This includes antibodies that can be used for protein and protein complex analysis. Research and development of new biomarkers and diagnostic products are of great importance at Bioporto A/S. The company continually invests in the development of new tests and test kits to expand its product range and meet the ever-growing demands of medical diagnostics. Overall, Bioporto A/S is an innovative company playing an important role in medical diagnostics. With its high-quality products and close collaboration with partners in research and development, Bioporto A/S ensures it will continue to play a significant role in the identification and development of biomarkers and diagnostic products in the future. Bioporto A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Bioporto A/S's Equity

Bioporto A/S's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Bioporto A/S's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Bioporto A/S's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Bioporto A/S's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Bioporto A/S’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Bioporto A/S Stock

What is the equity of Bioporto A/S this year?

Bioporto A/S has equity of 60.16 M DKK this year.

What was the equity of Bioporto A/S compared to the previous year?

The equity of Bioporto A/S has increased/decreased by -14.33% decreased compared to the previous year.

What impact does a high equity have on investors of Bioporto A/S?

A high equity is advantageous for investors of Bioporto A/S as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Bioporto A/S?

A low equity can be a risk for investors of Bioporto A/S, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Bioporto A/S affect the company?

An increase in equity of Bioporto A/S can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Bioporto A/S affect the company?

A reduction in equity of Bioporto A/S can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Bioporto A/S?

Some factors that can affect the equity of Bioporto A/S include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Bioporto A/S so important for investors?

The equity of Bioporto A/S is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Bioporto A/S take to change the equity?

To change equity, Bioporto A/S can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Bioporto A/S pay?

Over the past 12 months, Bioporto A/S paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bioporto A/S is expected to pay a dividend of 0 DKK.

What is the dividend yield of Bioporto A/S?

The current dividend yield of Bioporto A/S is .

When does Bioporto A/S pay dividends?

Bioporto A/S pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bioporto A/S?

Bioporto A/S paid dividends every year for the past 0 years.

What is the dividend of Bioporto A/S?

For the upcoming 12 months, dividends amounting to 0 DKK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bioporto A/S located?

Bioporto A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bioporto A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bioporto A/S from 5/31/2024 amounting to 0 DKK, you needed to have the stock in your portfolio before the ex-date on 5/31/2024.

When did Bioporto A/S pay the last dividend?

The last dividend was paid out on 5/31/2024.

What was the dividend of Bioporto A/S in the year 2023?

In the year 2023, Bioporto A/S distributed 0 DKK as dividends.

In which currency does Bioporto A/S pay out the dividend?

The dividends of Bioporto A/S are distributed in DKK.